BETA-CASEIN A2 UND REDUZIERUNG ODER VORBEUGUNG VON SYMPTOMEN EINER LACTOSEINTOLERANZ

European patent · EP3019180 · Deleted

Register entry

Publication number
EP3019180
Application number
EP14823628
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 10, 2014
Published
May 18, 2016
Granted
May 29, 2019
Deleted
Feb 7, 2024
Reason
Revoked in opposition
IPC classes
A61K 35/20 (2006.01)
A61P 1/00 (2006.01)
A61K 38/17 (2006.01)
A61K 9/00 (2006.01)
A23L 33/19 (2016.01)
Priority
US 201361845480 P 12.07.2013
PCT application
PCT/NZ2014/000141 10.07.2014
PCT publication
WO2015/005804 15.01.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 7, 2024

    Change

    Published in Swissreg on 07.02.2024

  2. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  3. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  4. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  5. May 29, 2019

    Granted

    Published in Swissreg on 29.05.2019

Parties

Holder

The a2 Milk Company Limited

The A2 Milk Company Limited

Level 10 51 Shortland Street, Auckland 1010, NZ

Inventor

TRIVEDI, Malav Suchin

Hollywood, Florida 33020, US

CLARKE, Andrew John

Auckland, 1052, NZ

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.